No photo of Michael A. Belshan

View Scopus Profile

Michael A. Belshan, PhD

Associate Professor

  • 588 Citations
  • 15 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael A. Belshan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
HIV-1 Medicine & Life Sciences
Equine infectious anemia virus Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
HIV Medicine & Life Sciences
efavirenz Medicine & Life Sciences
Nanoparticles Medicine & Life Sciences
HIV-2 Medicine & Life Sciences
Rilpivirine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2000 2016

CELLULAR INTERACTIONS OF HIV-2 VPX

Belshan, M. A.

National Institutes of Health

4/1/01 → …

Project: Research project

HIV-2
Nuclear Localization Signals
Cell Nucleus Active Transport
Retroviridae Proteins
Virus Integration

A Proteomic and Biochemical Study of HIV-1 Nucleoprotein Complexes

Belshan, M. A.

National Institutes of Health

5/1/10 → 4/30/16

Project: Research project

Nucleoproteins
Proteomics
HIV-1
Virus Replication
Proteins

NEBRASKA CENTER FOR VIRAL PATHOGENESIS

Bartz, J. C. & Belshan, M. A.

National Institutes of Health

9/30/00 → 9/23/11

Project: Research project

infrastructure
expertise
Cell Nucleus Active Transport
Prions
synergy

Research Output 1998 2019

  • 588 Citations
  • 15 h-Index
  • 29 Article
  • 1 Conference contribution
  • 1 Comment/debate
2 Citations (Scopus)

A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study

Mandal, S., Prathipati, P. K., Belshan, M. & Destache, C. J., Jul 1 2019, In : Antiviral Research. 167, p. 83-88 6 p.

Research output: Contribution to journal › Article

Drug Delivery Systems
HIV Infections
HIV-1
Integrases
Emulsions

CD4+ T cell activation and associated susceptibility to HIV-1 infection in vitro increased following acute resistance exercise in human subjects

Holbrook, A. K., Peterson, H. D., Bianchi, S. A., Macdonald, B. W., Bredahl, E. C., Belshan, M. & Siedlik, J. A., Sep 1 2019, In : Physiological Reports. 7, 18, e14234.

Research output: Contribution to journal › Article

Open Access
HIV Infections
HIV-1
Exercise
T-Lymphocytes
Leg
1 Citation (Scopus)

Proteomic profiling of HIV-infected T-cells by SWATH mass spectrometry

DeBoer, J., Wojtkiewicz, M. S., Haverland, N., Li, Y., Harwood, E., Leshen, E., George, J. W., Ciborowski, P. & Belshan, M. A., Mar 1 2018, In : Virology. 516, p. 246-257 12 p.

Research output: Contribution to journal › Article

Proteomics
Mass Spectrometry
HIV
T-Lymphocytes
Infection
12 Citations (Scopus)

An enhanced emtricitabine-loaded long-acting nanoformulation for prevention or treatment of HIV infection

Mandal, S., Belshan, M. A., Holec, A., Zhou, Y. & Destache, C. J., Jan 1 2017, In : Antimicrobial Agents and Chemotherapy. 61, 1, e01475-16.

Research output: Contribution to journal › Article

HIV Infections
Blood Cells
Nucleosides
Inhibitory Concentration 50
HIV-1
6 Citations (Scopus)

Cyclophilin B enhances HIV-1 infection

DeBoer, J., Madson, C. J. & Belshan, M. A., Feb 1 2016, In : Virology. 489, p. 282-291 10 p.

Research output: Contribution to journal › Article

HIV Infections
HIV-1
Nuclear Localization Signals
Cell Nucleus Active Transport
Immunophilins